Pending FDA total disc arthroplasty approvals and their effect on spinal clinical device trials
This article was originally published in Clinica
Executive Summary
In the latest in its series of commentaries on the orthopaedics industry, US merchant banking firm Viscogliosi Bros looks at how best to overcome resistance to enrolling patients in randomised clinical trials that include fusion procedures as the control group.